1. Home
  2. AVDL vs AMC Comparison

AVDL vs AMC Comparison

Compare AVDL & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • AMC
  • Stock Information
  • Founded
  • AVDL 2015
  • AMC 1920
  • Country
  • AVDL Ireland
  • AMC United States
  • Employees
  • AVDL N/A
  • AMC N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • AMC Movies/Entertainment
  • Sector
  • AVDL Health Care
  • AMC Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • AMC Nasdaq
  • Market Cap
  • AVDL 1.4B
  • AMC 1.3B
  • IPO Year
  • AVDL 1996
  • AMC 2013
  • Fundamental
  • Price
  • AVDL $14.54
  • AMC $2.82
  • Analyst Decision
  • AVDL Strong Buy
  • AMC Hold
  • Analyst Count
  • AVDL 7
  • AMC 7
  • Target Price
  • AVDL $19.86
  • AMC $3.94
  • AVG Volume (30 Days)
  • AVDL 1.4M
  • AMC 11.3M
  • Earning Date
  • AVDL 08-07-2025
  • AMC 08-11-2025
  • Dividend Yield
  • AVDL N/A
  • AMC N/A
  • EPS Growth
  • AVDL N/A
  • AMC N/A
  • EPS
  • AVDL N/A
  • AMC N/A
  • Revenue
  • AVDL $221,075,000.00
  • AMC $4,915,600,000.00
  • Revenue This Year
  • AVDL $63.77
  • AMC $7.93
  • Revenue Next Year
  • AVDL $29.91
  • AMC $6.63
  • P/E Ratio
  • AVDL N/A
  • AMC N/A
  • Revenue Growth
  • AVDL 132.35
  • AMC 9.42
  • 52 Week Low
  • AVDL $6.38
  • AMC $2.45
  • 52 Week High
  • AVDL $16.66
  • AMC $5.56
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 70.53
  • AMC 40.35
  • Support Level
  • AVDL $14.52
  • AMC $2.81
  • Resistance Level
  • AVDL $14.99
  • AMC $2.97
  • Average True Range (ATR)
  • AVDL 0.53
  • AMC 0.08
  • MACD
  • AVDL -0.00
  • AMC -0.01
  • Stochastic Oscillator
  • AVDL 63.55
  • AMC 4.29

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

Share on Social Networks: